<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Fan J</submitter><pubmed_abstract>&lt;b>Background:&lt;/b> Osteoporosis (OP) is a serious and common bone metabolic disease with bone mass loss and bone microarchitectural deterioration. The OSTEOWONDER capsule is clinically used to treat OP. However, the potential regulatory mechanism of the OSTEOWONDER capsule in treatment of OP remains largely unknown. &lt;b>Methods:&lt;/b> The bioactive compounds of herbs and their targets were identified using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) database. The speculative targets of OP were screened out based on GeneCards, DisGeNET, and Online Mendelian Inheritance in Man (OMIM) databases. The gene modules and hub genes of OP were identified using a weighted gene co-expression network analysis (WGCNA). Then, an herb-compound-target network w</pubmed_abstract><journal>Frontiers in genetics</journal><pagination>833027</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8918533</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Network Pharmacology and Molecular Docking Elucidate the Pharmacological Mechanism of the OSTEOWONDER Capsule for Treating Osteoporosis.</pubmed_title><pmcid>PMC8918533</pmcid><pubmed_authors>Peng H</pubmed_authors><pubmed_authors>Peng Y</pubmed_authors><pubmed_authors>Luo Q</pubmed_authors><pubmed_authors>Meng S</pubmed_authors><pubmed_authors>Dai L</pubmed_authors><pubmed_authors>Fan J</pubmed_authors><pubmed_authors>Qu Z</pubmed_authors><pubmed_authors>Liu T</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Network Pharmacology and Molecular Docking Elucidate the Pharmacological Mechanism of the OSTEOWONDER Capsule for Treating Osteoporosis.</name><description>&lt;b>Background:&lt;/b> Osteoporosis (OP) is a serious and common bone metabolic disease with bone mass loss and bone microarchitectural deterioration. The OSTEOWONDER capsule is clinically used to treat OP. However, the potential regulatory mechanism of the OSTEOWONDER capsule in treatment of OP remains largely unknown. &lt;b>Methods:&lt;/b> The bioactive compounds of herbs and their targets were identified using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) database. The speculative targets of OP were screened out based on GeneCards, DisGeNET, and Online Mendelian Inheritance in Man (OMIM) databases. The gene modules and hub genes of OP were identified using a weighted gene co-expression network analysis (WGCNA). Then, an herb-compound-target network w</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-26T04:36:49.227Z</modification><creation>2025-04-06T11:15:49.51Z</creation></dates><accession>S-EPMC8918533</accession><cross_references><pubmed>35295951</pubmed><doi>10.3389/fgene.2022.833027</doi></cross_references></HashMap>